Solubility diagrams of the potassium iodide-water-N,N-dimethylformamide and iodine-iodide-water-N,N-dimethylformamide systems at 25°C

2006 ◽  
Vol 80 (10) ◽  
pp. 1671-1675 ◽  
Author(s):  
T. M. Varlamova ◽  
G. V. Gerasimova ◽  
S. P. Mushtakova
Ob Gyn News ◽  
2011 ◽  
Vol 46 (4) ◽  
pp. 2
Author(s):  
SHERRY BOSCHERT
Keyword(s):  

2011 ◽  
Vol 44 (6) ◽  
pp. 5
Author(s):  
SHERRY BOSCHERT
Keyword(s):  

JAMA ◽  
1967 ◽  
Vol 200 (12) ◽  
pp. 1036-1040 ◽  
Author(s):  
M. Blum
Keyword(s):  

1986 ◽  
Vol 25 (06) ◽  
pp. 227-231 ◽  
Author(s):  
Chr. Eilles ◽  
W. Spiegel ◽  
W. Becker ◽  
W. Börner ◽  
Chr. Reiners

The monoclonal anti-CEA F(ab’)2 fragment MAb BW 431/31, labelled with 123I or111 In, was used for immunoscintigraphy (IS) in 9 patients with medullary cancer of the thyroid (CCC). The results of 11 studies lead to the following conclusions: 1) When using radioiodine as a label for MAb in IS, potassium iodide is absolutely necessary to block the thyroid which is of special importance in patients with thyroid cancer; 2) Preinjection of “cold” MAb reduces the relatively high unspecific uptake (especially in bone marrow) of MAb BW 431/31, which is of special importance for the antibody labelled with 111 In; 3) IS with MAb BW 413/31 in patients with CCC and elevated serum CEA is positive only in cases with large secondaries; and 4) In patients with CCC and several manifestations of secondaries, only a single (large) metastasis may be apparent.


Sign in / Sign up

Export Citation Format

Share Document